Cargando…
No expenditure difference among patients with liver cancer at stage I−IV: Findings from a multicenter cross-sectional study in China
OBJECTIVE: The number of liver cancer patients in China accounts for more than half of the world. However, China currently lacks national, multicenter economic burden data, and meanwhile, measuring the differences among different subgroups will be informative to formulate corresponding policies in l...
Autores principales: | Lei, Haike, Lei, Lin, Shi, Jufang, Wu, Yongzhong, Liang, Ling, Huang, Huiyao, He, Mei, Bai, Fangzhou, Cao, Maomao, Qiu, Hui, Wang, Yuting, Liu, Chengcheng, Du, Jia, Wang, Hong, Zhang, Yan, Cao, Mengdi, Peng, Ji, Li, Ni, Qu, Chunfeng, Dai, Min, Chen, Wanqing, He, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491539/ https://www.ncbi.nlm.nih.gov/pubmed/32963464 http://dx.doi.org/10.21147/j.issn.1000-9604.2020.04.09 |
Ejemplares similares
-
Medical expenditures for colorectal cancer diagnosis and treatment: A 10-year high-level-hospital-based multicenter retrospective survey in China, 2002−2011
por: Shi, Jufang, et al.
Publicado: (2019) -
Expenditure and Financial Burden for Stomach Cancer Diagnosis and Treatment in China: A Multicenter Study
por: Zhang, Kai, et al.
Publicado: (2020) -
Classifying risk level of gastric cancer: Evaluation of questionnaire-based prediction model
por: Cao, Maomao, et al.
Publicado: (2020) -
The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective
por: Cao, Meng-Di, et al.
Publicado: (2022) -
Trends and risk factors of lung cancer in China
por: He, Siyi, et al.
Publicado: (2020)